Jan 8, 2026 08:59AM
Jan 7, 2026 08:47AM
Jan 2, 2026 09:05AM
Dec 30, 2025 09:57AM
Dec 29, 2025 08:49AM
Dec 22, 2025 09:13AM
Dec 19, 2025 08:27AM Attention Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Holley Inc. (NYSE: HLLY); Molina Healthcare, Inc. (NYSE: MOH); and WEBTOON Entertainment, Inc. (NASDAQ: WBTN): Grabar Law Office
Dec 16, 2025 08:40AM
Dec 12, 2025 02:37PM
Dec 9, 2025 09:18AM
Dec 8, 2025 08:35AM
Dec 4, 2025 12:05PM
Dec 2, 2025 12:39PM
Dec 1, 2025 08:44AM Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Ibotta, Inc. (NYSE: IBTA); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar
Nov 26, 2025 10:46AM
Nov 24, 2025 08:43AM
Nov 19, 2025 08:50AM
Nov 18, 2025 08:43AM
Sep 24, 2025 11:01AM
Sep 23, 2025 12:53PM
May 6, 2025 04:00PM Cytokinetics Reports First Quarter 2025 Financial Results and Provides Business Update
Jan 13, 2025 12:50PM
Dec 3, 2024 06:59AM
Dec 2, 2024 07:31AM
Dec 2, 2024 07:30AM
Aug 13, 2024 03:26AM
Dec 13, 2022 05:45PM
Dec 13, 2022 07:04AM Cytokinetics (CYTK) Stock Trading Halted Today Due to FDA Meeting to Review NDA for Omecamtiv Mecarbil
Dec 13, 2022 07:02AM
Dec 9, 2022 09:03AM
Dec 9, 2022 08:59AM
Nov 3, 2022 04:00PM
Aug 4, 2022 04:00PM
Jun 24, 2022 07:31AM
Jun 24, 2022 07:30AM Cytokinetics Announces Date for FDA Advisory Committee Meeting to Review New Drug Application for Omecamtiv Mecarbil
May 17, 2022 07:32AM
May 17, 2022 07:30AM
Feb 16, 2022 06:17AM
Feb 4, 2022 10:19AM
Feb 4, 2022 10:06AM
Feb 4, 2022 07:30AM
Feb 4, 2022 07:30AM Cytokinetics Announces FDA Acceptance of New Drug Application for Omecamtiv Mecarbil for the Treatment of Heart Failure With Reduced Ejection Fraction

15,627 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All